Nisa Investment Advisors
IBRX icon

Nisa Investment Advisors’s ImmunityBio IBRX Stock Holding History

Nisa Investment Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3K Sell
4,601
-10,415
-69% -$78.8K ﹤0.01% 1935
2026
Q1 		$115K Buy
15,016
+12,874
+601% +$88.1K ﹤0.01% 1377
2025
Q4 		$4.24K Sell
2,142
-78
-4% -$177 ﹤0.01% 2483
2025
Q3 		$5.46K Sell
2,220
-143
-6% -$368 ﹤0.01% 2423
2025
Q2 		$6.24K Buy
2,363
+1,373
+139% +$3.69K ﹤0.01% 2405
2025
Q1 		$2.98K Buy
990
+639
+182% +$1.94K ﹤0.01% 2368
2024
Q4 		$899 Sell
351
-49
-12% -$204 ﹤0.01% 2707
2024
Q3 		$1.49K Buy
400
+86
+27% +$398 ﹤0.01% 2480
2024
Q2 		$1.98K Buy
314
+118
+60% +$778 ﹤0.01% 2376
2024
Q1 		$1.05K Buy
196
+126
+180% +$571 ﹤0.01% 2361
2023
Q4 		$351 Sell
70
-163
-70% -$511 ﹤0.01% 2474
2023
Q3 		$394 Buy
+233
New +$468 ﹤0.01% 2563
2023
Q1 		– Sell
-117
Closed -$1K – 2597
2022
Q4 		$1K Sell
117
-5,043
-98% -$27.7K ﹤0.01% 2444
2022
Q3 		$27K Buy
+5,160
New +$23.5K ﹤0.01% 1965
2022
Q2 		– Sell
-1,600
Closed -$9K – 2430
2022
Q1 		$9K Buy
+1,600
New +$9.82K ﹤0.01% 2232
2021
Q1 		– Sell
-19,500
Closed -$260K – 2306
2020
Q4 		$260K Buy
+19,500
New +$188K ﹤0.01% 1363
2017
Q3 		– Sell
-12,700
Closed -$100K – 1852
2017
Q2 		$100K Buy
+12,700
New +$54.9K ﹤0.01% 1346

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nisa Investment Advisors's IBRX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its ImmunityBio (IBRX) stake by 69% in Q2 2026, selling an estimated $78.8K and leaving 4,601 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

Nisa Investment Advisors first reported a position in IBRX in Q2 2017 and has held it in 17 quarters since. The position peaked at $260K in Q4 2020. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Nisa Investment Advisors held 4,601 shares of ImmunityBio worth $40.3K as of Q2 2026.
  • Nisa Investment Advisors sold 10,415 ImmunityBio shares in Q2 2026, an estimated $78.8K.
  • ImmunityBio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1935 holding.
  • Nisa Investment Advisors first reported a position in ImmunityBio in Q2 2017 and has held it in 17 quarters since.
  • Nisa Investment Advisors's ImmunityBio position peaked at $260K in Q4 2020.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.